TET1 Suppresses Cancer Invasion by Activating the Tissue Inhibitors of Metalloproteinases

Chih-Hung Hsu, Kai-Lin Peng, Ming-Lun Kang, Yi-Ren Chen, Yu-Chih Yang, Chin-Hsien Tsai, Chi-Shen Chu, Yung-Ming Jeng, Yen-Ting Chen, Feng-Mao Lin, Hsien-Da Huang, Yun-Yuh Lu, Yu-Ching Teng, Shinn-Tsuen Lin, Ruo Kai Lin, Fan-Mei Tang, Sung-Bau Lee, Huan-Ming Hsu, Jyh-Cherng Yu, Pei-Wen HsiaoLi-Jung Juan

研究成果: 雜誌貢獻文章同行評審

220 引文 斯高帕斯(Scopus)


Tumor suppressor gene silencing through cytosine methylation contributes to cancer formation. Whether DNA demethylation enzymes counteract this oncogenic effect is unknown. Here, we show that TET1, a dioxygenase involved in cytosine demethylation, is downregulated in prostate and breast cancer tissues. TET1 depletion facilitates cell invasion, tumor growth, and cancer metastasis in prostate xenograft models and correlates with poor survival rates in breast cancer patients. Consistently, enforced expression of TET1 reduces cell invasion and breast xenograft tumor formation. Mechanistically, TET1 suppresses cell invasion through its dioxygenase and DNA binding activities. Furthermore, TET1 maintains the expression of tissue inhibitors of metalloproteinase (TIMP) family proteins 2 and 3 by inhibiting their DNA methylation. Concurrent low expression of TET1 and TIMP2 or TIMP3 correlates with advanced node status in clinical samples. Together, these results illustrate a mechanism by which TET1 suppresses tumor development and invasion partly through downregulation of critical gene methylation
頁(從 - 到)568-579
期刊Cell Reports
出版狀態已發佈 - 9月 27 2012


  • dioxygenase
  • DNA
  • protein TET1
  • tissue inhibitor of metalloproteinase 2
  • tissue inhibitor of metalloproteinase 3
  • unclassified drug

ASJC Scopus subject areas

  • 生物化學、遺傳與分子生物學 (全部)


深入研究「TET1 Suppresses Cancer Invasion by Activating the Tissue Inhibitors of Metalloproteinases」主題。共同形成了獨特的指紋。